Krystal Biotech (KRYS) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Krystal Biotech (KRYS) over the last 5 years, with Q4 2025 value amounting to $1.7.
- Krystal Biotech's EPS (Weighted Average and Diluted) rose 1111.11% to $1.7 in Q4 2025 from the same period last year, while for Dec 2025 it was $6.85, marking a year-over-year increase of 12833.33%. This contributed to the annual value of $6.84 for FY2025, which is 12800.0% up from last year.
- As of Q4 2025, Krystal Biotech's EPS (Weighted Average and Diluted) stood at $1.7, which was up 1111.11% from $2.66 recorded in Q3 2025.
- Krystal Biotech's 5-year EPS (Weighted Average and Diluted) high stood at $2.79 for Q3 2023, and its period low was -$1.99 during Q1 2022.
- Over the past 5 years, Krystal Biotech's median EPS (Weighted Average and Diluted) value was -$0.34 (recorded in 2021), while the average stood at $0.07.
- As far as peak fluctuations go, Krystal Biotech's EPS (Weighted Average and Diluted) crashed by 16885.03% in 2022, and later skyrocketed by 390000.0% in 2025.
- Over the past 5 years, Krystal Biotech's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.95 in 2021, then tumbled by 31.58% to -$1.25 in 2022, then skyrocketed by 124.8% to $0.31 in 2023, then surged by 393.55% to $1.53 in 2024, then grew by 11.11% to $1.7 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $1.7 for Q4 2025, versus $2.66 for Q3 2025 and $1.29 for Q2 2025.